Healthcare provider profile · identity verified

Stephen Kimmel, MD

Family Practice · BURNSVILLE, NC · NPI 1467847160

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	416	121
Atorvastatin Calcium	Atorvastatin Calcium	362	102
Losartan Potassium	Losartan Potassium	287	77
Lisinopril	Lisinopril	283	80
Amlodipine Besylate	Amlodipine Besylate	268	75
Levothyroxine Sodium	Levothyroxine Sodium	258	71
Omeprazole	Omeprazole	258	79
Hydrochlorothiazide	Hydrochlorothiazide	202	56
Metoprolol Succinate	Metoprolol Succinate	191	61
Gabapentin	Gabapentin	181	41
Metformin Hcl Er	Metformin Hcl	161	41
Ozempic	Semaglutide	156	27
Eliquis	Apixaban	141	29
Albuterol Sulfate Hfa	Albuterol Sulfate	130	45
Tamsulosin Hcl	Tamsulosin Hcl	123	40
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	120	19
Tramadol Hcl	Tramadol Hcl	109	21
Pantoprazole Sodium	Pantoprazole Sodium	105	37
Sertraline Hcl	Sertraline Hcl	103	30
Allopurinol	Allopurinol	101	25
Jardiance	Empagliflozin	101	27
Oxycodone Hcl	Oxycodone Hcl	100	20
Escitalopram Oxalate	Escitalopram Oxalate	98	27
Clonazepam	Clonazepam	96	14
Zolpidem Tartrate	Zolpidem Tartrate	95	12
Telmisartan	Telmisartan	94	31
Pravastatin Sodium	Pravastatin Sodium	93	23
Alendronate Sodium	Alendronate Sodium	88	31
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	85	14
Buprenorphine Hcl	Buprenorphine Hcl	79	suppressed
Duloxetine Hcl	Duloxetine Hcl	78	19
Famotidine	Famotidine	78	22
Fluticasone Propionate	Fluticasone Propionate	75	29
Meloxicam	Meloxicam	74	21
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	72	suppressed
Trazodone Hcl	Trazodone Hcl	71	21
Pregabalin	Pregabalin	70	14
Symbicort	Budesonide/Formoterol Fumarate	69	18
Spironolactone	Spironolactone	66	23
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	62	24
Furosemide	Furosemide	60	23
Alprazolam	Alprazolam	59	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	58	21
Ondansetron Hcl	Ondansetron Hcl	55	suppressed
Montelukast Sodium	Montelukast Sodium	53	18
Carvedilol	Carvedilol	51	14
Ezetimibe	Ezetimibe	50	18
Potassium Chloride	Potassium Chloride	49	16
Finasteride	Finasteride	48	12
Metoprolol Tartrate	Metoprolol Tartrate	48	16
Mirtazapine	Mirtazapine	48	11
Simvastatin	Simvastatin	45	15
Buspirone Hcl	Buspirone Hcl	44	12
Metformin Hcl	Metformin Hcl	44	15
Clopidogrel	Clopidogrel Bisulfate	41	14
Paroxetine Hcl	Paroxetine Hcl	38	suppressed
Lorazepam	Lorazepam	37	suppressed
Ropinirole Hcl	Ropinirole Hcl	36	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	36	suppressed
Diazepam	Diazepam	35	suppressed
Ventolin Hfa	Albuterol Sulfate	35	suppressed
Atenolol	Atenolol	34	suppressed
Ondansetron Odt	Ondansetron	33	15
Trulicity	Dulaglutide	33	suppressed
Tizanidine Hcl	Tizanidine Hcl	32	11
Xarelto	Rivaroxaban	32	suppressed
Citalopram Hbr	Citalopram Hydrobromide	31	12
Venlafaxine Hcl Er	Venlafaxine Hcl	31	suppressed
Azelastine Hcl	Azelastine Hcl	30	17
Triamcinolone Acetonide	Triamcinolone Acetonide	30	20
Mounjaro	Tirzepatide	28	suppressed
Bumetanide	Bumetanide	26	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	26	11
Estradiol	Estradiol	26	suppressed
Lidocaine Hcl Viscous	Lidocaine Hcl	26	suppressed
Repatha Sureclick	Evolocumab	26	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	25	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	24	suppressed
Nystatin	Nystatin	23	12
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	22	suppressed
Celecoxib	Celecoxib	22	suppressed
Irbesartan	Irbesartan	22	suppressed
Bupropion Xl	Bupropion Hcl	21	suppressed
Diclofenac Sodium	Diclofenac Sodium	21	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	21	suppressed
Warfarin Sodium	Warfarin Sodium	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	20	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	20	suppressed
Lovastatin	Lovastatin	20	suppressed
Meclizine Hcl	Meclizine Hcl	20	suppressed
Donepezil Hcl	Donepezil Hcl	19	suppressed
Januvia	Sitagliptin Phosphate	18	suppressed
Mupirocin	Mupirocin	18	11
Baclofen	Baclofen	17	suppressed
Chlorthalidone	Chlorthalidone	17	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	17	suppressed
Glipizide Er	Glipizide	17	suppressed
Amoxicillin	Amoxicillin	16	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	15	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	15	suppressed
Acyclovir	Acyclovir	14	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	14	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	13	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Klor-Con M20	Potassium Chloride	13	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	13	suppressed
Primidone	Primidone	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Synthroid	Levothyroxine Sodium	13	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	12	suppressed
Colchicine	Colchicine	12	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Methadone Hcl	Methadone Hcl	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Praluent Pen	Alirocumab	12	suppressed
Sildenafil Citrate	Sildenafil Citrate	12	suppressed
Xtampza Er	Oxycodone Myristate	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	11
Hydroxyzine Pamoate	Hydroxyzine Pamoate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error